Abstract
Initiation of centrosome duplication and DNA replication is coupled, which is primarily achieved by the late G1 phase-specific activation of cyclin-dependent kinase 2 (CDK2)-cyclin E, which triggers both centrosome duplication and DNA replication. Uncoupling of these two events contributes to overduplication of centrosomes, resulting in the presence of more than two centrosomes (centrosome amplification). Centrosome amplification, which is frequently observed in cancers, contributes to tumor development through destabilizing genomes. Nucleophosmin (NPM/B23) is one of the phosphorylation targets of CDK2-cyclin E for the initiation of centrosome duplication. It has been found that NPM/B23 phosphorylated on Thr199 by CDK2-cyclin E acquires a high binding affinity to ROCK II kinase. The Thr199-phosphorylated NPM/B23 physically interacts with and super-activates the centrosomally localized ROCK II, which is a critical event for centrosomes to initiate duplication. Here, we provide direct evidence for the activation of ROCK II as a primary and sufficient downstream event of CDK2-cyclin E for the initiation of centrosome duplication and for the induction of centrosome amplification.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amano M, Chihara K, Nakamura N, Kaneko T, Matsuura Y, Kaibuchi K . (1999). The COOH-terminus of Rho-kinase negatively regulates rho-kinase activity. J Biol Chem 274: 32418–32424.
Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T et al. (1996). Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246–20249.
Balczon R, Bao L, Zimmer WE, Brown K, Zinkowski RP, Brinkley BR . (1995). Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol 130: 105–115.
Chen Z, Indjeian VB, McManus M, Wang L, Dynlacht BD . (2002). CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev Cell 3: 339–350.
D'Assoro AB, Lingle WL, Salisbury JL . (2002). Centrosome amplification and the development of cancer. Oncogene 21: 6146–6153.
Doxsey S . (2001). Re-evaluating centrosome function. Nat Rev Mol Cell Biol 2: 688–698.
Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ et al. (1999). Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274: 37385–37390.
Ferretti R, Palumbo V, Di Savino A, Velasco S, Sbroggiò M, Sportoletti P et al. (2010). Morgana/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis. Dev Cell 18: 486–495.
Fisk HA, Winey M . (2001). The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106: 95–104.
Fukasawa K . (2005). Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230: 6–19.
Fukasawa K . (2007). Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 7: 911–924.
Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S et al. (2003). Cyclin E ablation in the mouse. Cell 114: 431–443.
Hanashiro K, Kanai M, Geng Y, Sicinski P, Fukasawa K . (2008). Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells. Oncogene 27: 5288–5302.
Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G . (1999). Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283: 851–854.
Hinchcliffe EH, Sluder G . (2002). Two for two: Cdk2 and its role in centrosome doubling. Oncogene 21: 6154–6160.
Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y et al. (2003). Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9: 2632–2641.
Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, Ito Y et al. (2004). Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 10: 4799–4805.
Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M et al. (1996). Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245–248.
Lacey KR, Jackson PK, Stearns T . (1999). Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci USA 96: 2817–2822.
Leung T, Chen XQ, Manser E, Lim L . (1996). The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 16: 5313–5327.
Ma Z, Kanai M, Kawamura K, Kaibuchi K, Ye K, Fukasawa K . (2006). Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication. Mol Cell Biol 26: 9016–9034.
Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M et al. (1996). Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15: 2208–2216.
Matsumoto Y, Hayashi K, Nishida E . (1999). Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol 9: 429–432.
Morgan DO . (1997). Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13: 261–291.
Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S . (1996). ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392: 189–193.
Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK et al. (2000). Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103: 127–140.
Ridley AJ . (2004). Rho proteins and cancer. Breast Cancer Res Treat 84: 13–19.
Sahai E, Marshall CJ . (2002). RHO-GTPases and cancer. Nat Rev Cancer 2: 133–142.
Tarapore P, Horn HF, Tokuyama Y, Fukasawa K . (2001). Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene 20: 3173–3184.
Tokuyama Y, Horn HF, Kawamura K, Tarapore P, Fukasawa K . (2001). Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 276: 21529–21537.
Totsukawa G, Yamakita Y, Yamashiro S, Hartshorne DJ, Sasaki Y, Matsumura F . (2000). Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 150: 797–806.
Wong CC, Wong CM, Tung EK, Man K, Ng IO . (2009). Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology 49: 1583–1594.
Wu J, Luo S, Jiang H, Li H . (2005). Mammalian CHORD-containing protein 1 is a novel heat shock protein 90-interacting protein. FEBS Lett 579: 421–426.
Acknowledgements
Cyclin E−/− MEFs lacking functional p53 were provided by Dr P Sicinski (Harvard Medical School), and p53−/− MEFs from Dr Donehower (Baylor College of Medicine). We thank M Crow, B Nepon-Sixt and M Rowland for technical assistance, and M Lloyd and J Johnson for technical assistance on microscopic analysis. This research is supported by the grants from the National Institutes of Health (CA90522 and GM87328) to KF and from AIRC2008 to MB.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Hanashiro, K., Brancaccio, M. & Fukasawa, K. Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification. Oncogene 30, 2188–2197 (2011). https://doi.org/10.1038/onc.2010.607
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.607
Keywords
This article is cited by
-
RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer
Journal of Experimental & Clinical Cancer Research (2019)
-
Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling
Nature Communications (2017)